<DOC>
	<DOCNO>NCT02670655</DOCNO>
	<brief_summary>Iontophoresis transdermal drug-delivery technique enhance transport ionic specie across membrane may significant benefit treatment actinic keratosis ( AK ) ablative fractional laser-primed photodynamic therapy ( AFL-PDT ) .</brief_summary>
	<brief_title>Efficacy Iontophoresis-assisted AFL-PDT Actinic Keratosis</brief_title>
	<detailed_description>Photodynamic therapy ( PDT ) methyl-aminolevulinate ( MAL ) effective treatment actinic keratosis ( AK ) . Many strategy study improve production protoporphyrin IX ( PpIX ) , improve efficacy PDT . Pre-treatment skin fractional laser resurface novel alternative technique improve efficacy PDT AK . Our previous study show ablative fractional laser-primed PDT ( AFL-PDT ) offer high efficacy conventional MAL-PDT treatment many disease , AK , actinic cheilitis , Bowen 's disease basal cell carcinoma.1-4 Iontophoresis another method improve efficacy PDT . Iontophoresis transdermal drug-delivery technique use mild electric current enhance transport ionic specie across membrane . Iontophoresis widely use enhance drug delivery . Mizutani K et al.5 report 5 AK patient successfully treat direct-current pulsed iontophoresis-assisted 5-aminolevulinic acid ( ALA ) -PDT . Boddé HE et al.6 study iontophoretic transport ALA quantitatively vitro demonstrate enhanced transport ALA iontophoresis . Until , appropriate incubation time AFL-PDT elucidate . In previous study , investigate efficacy AFL-PDT short incubation time.7 Although AFL-PDT short incubation time ( 2 h ) show enhanced efficacy conventional MAL-PDT standard incubation time , standard AFL-PDT 3-h incubation time show significantly high efficacy AFL-PDT short incubation time . The aim study evaluate efficacy iontophoresis AFL-PDT AK treatment . Consequently , compare efficacy , recurrence rate , cosmetic outcome safety iontophoresis-assisted AFL-PDT 2-h incubation time conventional AFL-PDT 2-h 3-h incubation time .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Prilocaine</mesh_term>
	<mesh_term>EMLA</mesh_term>
	<criteria>Korean patient age ≥ 18 year biopsyconfirmed AK lesion lactate pregnant woman patient porphyria know allergy constituent MAL cream lidocaine patient systemic disease , history malignant melanoma , tendency melasma development keloid formation , AK treatment area previous 4 week , condition associate risk poor protocol compliance ; patient immunosuppressive treatment metalcontaining device ( cardiac pacemaker , orthopaedic implant , gynaecological device ) cardiac arrhythmia large skin erosion</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Ablative fractional laser</keyword>
	<keyword>Iontophoresis</keyword>
	<keyword>Actinic keratosis</keyword>
	<keyword>Photodynamic therapy</keyword>
</DOC>